NPS PHARMACEUTICALS INC's ticker is P103PS and the CUSIP is 62936P103. A total of 2 filers reported holding NPS PHARMACEUTICALS INC in Q1 2015. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2014 | $233,000 | -54.0% | 6,510 | -57.5% | 0.02% | -50.0% |
| Q2 2014 | $507,000 | -48.3% | 15,335 | -52.5% | 0.04% | -58.0% |
| Q4 2013 | $981,000 | -11.5% | 32,315 | -7.2% | 0.10% | -14.5% |
| Q3 2013 | $1,108,000 | +214.8% | 34,830 | +49.5% | 0.12% | +178.6% |
| Q2 2013 | $352,000 | – | 23,290 | – | 0.04% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| HARVEY CAPITAL MANAGEMENT INC | 424,175 | $12,695,000 | 5.06% |
| Opaleye Management Inc. | 150,000 | $4,490,000 | 3.32% |
| OAK RIDGE INVESTMENTS LLC | 2,795,331 | $83,664,000 | 2.10% |
| SCHOLTZ & COMPANY, LLC | 60,350 | $1,806,000 | 1.94% |
| SECTORAL ASSET MANAGEMENT INC | 1,408,729 | $42,163,000 | 1.73% |
| First Light Asset Management, LLC | 79,099 | $2,367,000 | 1.68% |
| FCG ADVISORS, LLC | 71,146 | $2,129,000 | 1.51% |
| Rhenman & Partners Asset Management AB | 166,970 | $4,997,000 | 1.50% |
| BENDER ROBERT & ASSOCIATES | 73,611 | $2,203,000 | 1.48% |
| Eventide Asset Management | 283,900 | $8,497,000 | 1.32% |